Bengt Rasmussen
4PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 08, 2025
Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide.Bengt Rasmussen, Lars Nilsson, Magnus Tobiasson
|Jan 17, 2024
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.Magnus Tobiasson, Tatjana Pandzic, Johanna Illman
|Mar 17, 2023
Therapy-related MDS dissected based on primary disease and treatment-a nationwide perspective.Daniel Moreno Berggren, Hege Garelius, Petter Willner Hjelm
|Mar 12, 2022
"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".Bengt Rasmussen, Gudrun Göhring, Elsa Bernard
Pageof 1
Frequent Collaborators
3 joint publications
Eva Hellström-Lindberg
1 joint publications
Kirsten Grønbaek
1 joint publications
Elli Papaemmanuil
1 joint publications
Jan Maxwell Nørgaard
1 joint publications
Daniel Moreno Berggren
1 joint publications
Caroline E Weibull
1 joint publications
Magnus Tobiasson
1 joint publications
Duruta Weber
1 joint publications
Carolin Lindholm
1 joint publications
Marios Dimitriou
